KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Encompass Health (EHC) Other Operating Expenses (2016 - 2026)

Encompass Health (EHC) has disclosed Other Operating Expenses for 18 consecutive years, with $1.2 billion as the latest value for Q1 2026.

  • For Q1 2026, Other Operating Expenses rose 7.98% year-over-year to $1.2 billion; the TTM value through Mar 2026 reached $4.7 billion, up 8.21%, while the annual FY2025 figure was $4.4 billion, 7.83% up from the prior year.
  • Other Operating Expenses hit $1.2 billion in Q1 2026 for Encompass Health, up from $1.2 billion in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $1.2 billion in Q1 2026 and bottomed at $869.3 million in Q1 2022.
  • Average Other Operating Expenses over 5 years is $1.0 billion, with a median of $1.0 billion recorded in 2024.
  • Year-over-year, Other Operating Expenses decreased 13.57% in 2022 and then rose 12.78% in 2024.
  • Encompass Health's Other Operating Expenses stood at $914.8 million in 2022, then rose by 9.73% to $1.0 billion in 2023, then increased by 11.4% to $1.1 billion in 2024, then increased by 6.67% to $1.2 billion in 2025, then rose by 2.85% to $1.2 billion in 2026.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $1.2 billion, $1.2 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.